Back

Five-year cardiovascular outcomes in patients with heart failure and opioid-related disorders: a retrospective cohort study

11 May 2024 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: Chronic heart failure - comorbidities 2 Comorbidities HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Joel Manuel Alejandro

University of Maryland, Baltimore (United States of America)

7 More presentations in this session

Presentation thumbnail
The relationship between anemia and echocardiographic features and all-cause death in patients with heart failure with preserved ejection fraction
Associate Professor B. MURAT (Eskisehir, TR)
Abstract Slides Video
Presentation thumbnail
Heart transplant in patients with muscular dystrophy: a single-center experience.
Mr R. Valderrama Reyes (Newcastle-Upon-Tyne, GB)
Abstract Slides Video
Presentation thumbnail
Prognostic value of sarcopenia using six-minute walk test in patients with heart failure
Doctor D. Maeda (Tokyo, JP)
Abstract Slides Video
Presentation thumbnail
Myocardial performance improvement in heart failure patients after iron replacement: the IRON-PATH II echo-substudy
Doctor R. Ramos Polo (Hospitalet De Llobregat, ES)
Abstract Slides Video
Presentation thumbnail
Effect of oral semaglutide on global longitudinal strain and global myocardial work efficiency in patients with HFpEF, uncontrolled type 2 diabetes mellitus and obesity.
Doctor G. Armentaro (Catanzaro, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Chronic heart failure - comorbidities 2

The Event

Event poster

Heart Failure 2024

11 May - 14 May 2024
You may be interested in
thumbnail
Congress Presentation
Impact of cardiovascular diagnoses on buprenorphine initiation among patients with opioid use disorder
thumbnail
Congress Presentation
Effect of paracetamol on cardiovascular outcomes in patients with heart failure: a multi-center cohort study
thumbnail
Congress Presentation
Temporal Trends in HF Outcomes

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources